Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
International Journal of Cancer|December 20, 2007
Narrowing of the regions of allelic losses of chromosome 1p36 in meningioma tissues by an improved SSCP analysisYanlei Guan, Nobuhiro Hata, Daisuke Kuga, et al.Scientific Reports|October 1, 2020
Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumorsYuhei Sangatsuda, Fumihito Miura, Hiromitsu Araki, et al.Journal of Neuro-Oncology|July 29, 2021
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastomaKosuke Takigawa, Nobuhiro Hata, Yuhei Michiwaki, et al.Cancer Medicine|April 10, 2021
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastomaYusuke Funakoshi, Nobuhiro Hata, Kosuke Takigawa, et al.Journal of Neuro-Oncology|February 6, 2020
First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomideNobuhiro Hata, Masahiro Mizoguchi, Daisuke Kuga, et al.Clinical Neuroradiology|January 20, 2026
Time-intensity Profiles and T1-corrected Arterial Transit Time from Multi-delay Pseudo-continuous ASL with a Variable-TR Scheme for the Characterization of Adult-type Diffuse GliomaKoji Yamashita, Makoto Obara, Kazufumi Kikuchi, et al.Neuro-Oncology|November 9, 2025
Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomasYoshiki Arakawa, Ryuta Saito, Yonehiro Kanemura, et al.Journal of Neuropathology and Experimental Neurology|February 14, 2026
Molecular and clinical prognostic factors in isocitrate dehydrogenase-mutant astrocytomas: Insights into biomarker-driven stratificationNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.Brain Tumor Pathology|April 6, 2025
Analysis of clinical, histological, and genomic information of molecular glioblastoma in a Japanese glioma cohortRyutaro Makino, Madan Bajagain, Nayuta Higa, et al.Neuro-Oncology Advances|August 2, 2023
Favorable prognostic impact of <i>phosphatase and tensin homolog</i> alterations in wild-type isocitrate dehydrogenase and <i>telomerase reverse transcriptase</i> promoter glioblastomaNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.Pageof 11